Benjamin Miller

Researchers will use tissue-on-chip technology as a new way to explore the relationship between the lungs and brain.

Rochester is one of four NIH-sponsored centers that aims to produce tissue-on-chip devices as FDA-qualified drug development tools.

The inexpensive, portable device could help safeguard against future pandemics and detect viruses and infections in underserved populations.

‘Three Minute Thesis’ Competition winner Jeffrey Beard demonstrates how to communicate science to the public.

Researchers in Rochester are developing a “completely new diagnostic platform” that could prove to be a valuable clinical tool for detecting exposure to multiple viruses from a single drop of blood.

Rochester researchers are building technology to predict the course of tendon injuries—a form of personalized medicine that will lead to more effective treatments.

Nanomembranes, optical sensors, and blood analysis: Rochester faculty are turning previous research avenues to focus on ways to quickly detect novel coronavirus to speed treatment.

Todd Krauss, professor and chair of the Department of Chemistry, and Benjamin Miller, Dean’s Professor of Dermatology, are being recognized this year for their “efforts toward advancing scientific applications that are deemed scientifically or socially distinguished.”